🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to find the lowest dose of the cancer...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-06-01
Trial ID
NCT04142554
Treatments Being Tested
This is a prospective single-arm, multicenter, phase Ib clinical trial of P...
Status
Terminated
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2022-02-20
Trial ID
NCT05083208
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
The purpose of the study is to compare the efficacy of parsaclisib when com...
Status
Terminated
Location
Alaska Oncology and Hematology
Start Date
2021-05-24
Trial ID
NCT04551066
Treatments Being Tested
A Phase Ib/III, Multicenter, double-blinded study of Parsaclisib, a PI3Kδ I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-07-28
Trial ID
NCT05867030
Treatments Being Tested
This is an open-label, multicenter study to evaluate safety and tolerabilit...
Status
Active Not Recruiting
Location
Aichi Cancer Center Hospital
Start Date
2020-12-15
Trial ID
NCT04661007
Treatments Being Tested
This is a Phase 2, multicenter, open-label study to provide continued suppl...
Status
Active Not Recruiting
Location
Uab Comprehensive Cancer Center
Start Date
2020-08-03
Trial ID
NCT04509700
Treatments Being Tested
The purpose of the study is to compare the efficacy and safety of parsaclis...
Status
Terminated
Location
Sutter Health Alta Bates Summit Medical Center Absmc Alta Bates Summit Comprehensive Cancer Center
Start Date
2021-05-26
Trial ID
NCT04551053
Treatments Being Tested
wAIHA or EVANS syndrome: Linpriril 40mg, oral, once daily. The therapeutic ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07149818
Treatments Being Tested
The purpose of this study is to assess the objective response rate of parsa...
Status
Completed
Location
Arizona Oncology Associates - Biltmore Cancer Center
Start Date
2018-03-14
Trial ID
NCT03126019
Treatments Being Tested